Platinum Investment Management LTD Amgen Inc Transaction History

Platinum Investment Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $85,824 - $95,507	-372 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $6,797 - $7,519	-31 Reduced 7.69%	372 $90,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $2,334 - $2,735	-11 Reduced 2.66%	403 $86,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $12,426 - $14,481	56 Added 15.64%	414 $103,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $77,464 - $92,245	358 New	358 $82,000

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.